Pacific Biosciences of California (PACB) 8-K Results of Operations and Financial Condition

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Consolidated Balance Sheets

(Unaudited)

(in thousands except per share amounts)	December 31, 2012			December 31, 2011
Assets
Current assets
Cash and cash equivalents	$	46,540		$	58,865
Investments		54,040			118,569
Accounts receivable		2,822			4,557
Inventory, net		9,592			15,517
Prepaid expenses and other current assets		2,006			2,093
Total current assets		115,000			199,601
Property and equipment, net		14,329			18,398
Other long-term assets		354			317
Total assets	$	129,683		$	218,316
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	2,988		$	4,742
Accrued expenses and other current liabilities		8,204			10,258
Deferred revenue, current		3,378			4,236
Facility financing obligation, current		173			140
Total current liabilities		14,743			19,376
Deferred revenue, non-current		800			1,616
Deferred rent and other long-term liabilities		2,145			3,075
Facility financing obligation, non-current		2,613			2,786
Total liabilities		20,301			26,853
Stockholders’ equity
Preferred Stock, $0.001 par value: Authorized 50,000 shares; No shares issued or outstanding at December 31, 2012 and December 31, 2011		—			—
Common Stock and additional paid-in-capital, $0.001 par value: Authorized 1,000,000 shares; Issued and outstanding 56,170 shares at December 31, 2012 and 54,964 shares at December 31, 2011		645,372			632,961
Accumulated other comprehensive income		30			57
Accumulated deficit		(536,020	)		(441,555	)
Total stockholders’ equity		109,382			191,463
Total liabilities and stockholders’ equity	$	129,683		$	218,316